Pages that link to "Q35028158"
Jump to navigation
Jump to search
The following pages link to Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution (Q35028158):
Displaying 50 items.
- Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches (Q26774312) (← links)
- Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models (Q27012618) (← links)
- Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line (Q33969318) (← links)
- Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy (Q34399765) (← links)
- Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens (Q34624721) (← links)
- Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection (Q34635843) (← links)
- Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes (Q35079913) (← links)
- Possibilities for active immunotherapy of human cancer (Q35326752) (← links)
- Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance (Q35622889) (← links)
- T cell- but not tumor cell-produced TGF-β1 promotes the development of spontaneous mammary cancer (Q35764397) (← links)
- Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility (Q35855247) (← links)
- Radiation leukaemogenesis: is virus really necessary? (Q36042367) (← links)
- Incidence of spontaneous tumours in neonatally thymectomized rats (Q36042547) (← links)
- Cellular heterogeneity in a tissue culture cell line derived from a human bladder carcinoma (Q36047485) (← links)
- Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis (Q36347974) (← links)
- Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer (Q36353080) (← links)
- Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma (Q36356797) (← links)
- Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction (Q36369691) (← links)
- Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms (Q36379155) (← links)
- A tumor surveillance model: a non-coding RNA senses neoplastic cells and its protein partner signals cell death (Q36396528) (← links)
- The determinants of tumour immunogenicity (Q36555524) (← links)
- c-MYC impairs immunogenicity of human B cells (Q36786058) (← links)
- The adaptive immune response to sporadic cancer (Q36990593) (← links)
- Tumor immune therapy: lessons from infection and implications for cancer - can IL-7 help overcome immune inhibitory networks? (Q37762226) (← links)
- Combination approaches to immunotherapy: the radiotherapy example (Q37773250) (← links)
- Targeting stroma to treat cancers (Q37972797) (← links)
- T cell immunotherapy for melanoma from bedside to bench to barn and back: how conceptual advances in experimental mouse models can be translated into clinical benefit for patients (Q38101679) (← links)
- Curing tumor-bearing mice by shifting a Th2 to a Th1 anti-tumor response (Q39022359) (← links)
- Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance (Q39186289) (← links)
- Evolution of tumours and the impact of molecular oncology (Q39494403) (← links)
- Serological detection of a polyoma-tumor-associated membrane antigen (Q39554335) (← links)
- Viral Xenogenization of Intact Tumor Cells (Q39576343) (← links)
- Tumor Immunology in Domestic Animals (Q39595193) (← links)
- Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice (Q39655881) (← links)
- Review: biologic heterogeneity of cancer metastases (Q39657876) (← links)
- The Biology of Cancer Invasion and Metastasis (Q39775798) (← links)
- Suppressor Cells: Permitters and Promoters of Malignancy? (Q39805019) (← links)
- Suppressor cells of immune reactivity in malignancy (Q39877597) (← links)
- Lymphocyte-mediated lysis of tumor cells in vitro antigen-restricted clonal and unrestricted polyclonal effects (Q40105080) (← links)
- Intratumor immunologic heterogeneity (Q40107594) (← links)
- Concomitant Tumor Immunity and the Resistance to a Second Tumor Challenge (Q40107977) (← links)
- The In Vitro Generation of Effector Lymphocytes and Their Employment in Tumor Immunotherapy (Q40115119) (← links)
- Immunopathology of polyoma-induced tumors (Q40132082) (← links)
- Natural and induced immunity to mouse mammary tumors and the mammary tumor virus (MuMTV) (Q40132087) (← links)
- Phenotypic diversity in leukemia cell populations (Q40157386) (← links)
- Reflections on tumor origin, immunogenicity, and immunotherapy (Q40189082) (← links)
- Cell surface glycoprotein changes in Epstein-Barr virus-positive and -negative human hematopoietic cell lines (Q40224438) (← links)
- Direct gene transfer for treatment of human cancer (Q40937660) (← links)
- New bioassay for screening immunotoxic agents (Q41125263) (← links)
- George Klein: 1925-2016. (Q41677939) (← links)